1. Home
  2. IMAB vs FPI Comparison

IMAB vs FPI Comparison

Compare IMAB & FPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • FPI
  • Stock Information
  • Founded
  • IMAB 2014
  • FPI 2013
  • Country
  • IMAB United States
  • FPI United States
  • Employees
  • IMAB N/A
  • FPI N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • FPI Real Estate Investment Trusts
  • Sector
  • IMAB Health Care
  • FPI Real Estate
  • Exchange
  • IMAB Nasdaq
  • FPI Nasdaq
  • Market Cap
  • IMAB 394.2M
  • FPI 472.6M
  • IPO Year
  • IMAB 2020
  • FPI 2014
  • Fundamental
  • Price
  • IMAB $4.39
  • FPI $10.46
  • Analyst Decision
  • IMAB Strong Buy
  • FPI
  • Analyst Count
  • IMAB 6
  • FPI 0
  • Target Price
  • IMAB $7.17
  • FPI N/A
  • AVG Volume (30 Days)
  • IMAB 1.7M
  • FPI 330.4K
  • Earning Date
  • IMAB 11-02-2025
  • FPI 10-29-2025
  • Dividend Yield
  • IMAB N/A
  • FPI 2.29%
  • EPS Growth
  • IMAB N/A
  • FPI 229.01
  • EPS
  • IMAB N/A
  • FPI 1.21
  • Revenue
  • IMAB N/A
  • FPI $55,000,000.00
  • Revenue This Year
  • IMAB N/A
  • FPI N/A
  • Revenue Next Year
  • IMAB N/A
  • FPI N/A
  • P/E Ratio
  • IMAB N/A
  • FPI $8.70
  • Revenue Growth
  • IMAB N/A
  • FPI N/A
  • 52 Week Low
  • IMAB $0.60
  • FPI $9.66
  • 52 Week High
  • IMAB $5.90
  • FPI $12.87
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 59.97
  • FPI 34.65
  • Support Level
  • IMAB $3.98
  • FPI $10.56
  • Resistance Level
  • IMAB $4.51
  • FPI $10.85
  • Average True Range (ATR)
  • IMAB 0.30
  • FPI 0.15
  • MACD
  • IMAB 0.07
  • FPI -0.04
  • Stochastic Oscillator
  • IMAB 89.30
  • FPI 2.33

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

Share on Social Networks: